SOTATERCEPT-CSRK

CHEBI:CHEBI_747823

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
product_type
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
active_ingredient_strength
45 mg/mL
marketing_category
DRUG FOR FURTHER PROCESSING
labeler_name
Patheon Italia S.p.A.
manufacturer_name
Merck Sharp & Dohme LLC
marketing_start_date
20240326
package_marketing_start_date
26-MAR-24
generic_name
SOTATERCEPT-CSRK
product_ndc
68225-244
spl_id
100edb31-6d10-4b1a-af07-2982fe04e1b1
active_ingredient_name
SOTATERCEPT
package_ndc
68225-244-00
package_description
285 VIAL in 1 BOX (68225-244-00) / 1 mL in 1 VIAL
brand_name
WINREVAIR
brand_name_base
WINREVAIR
application_number
BLA761363
rxcui
2678951
spl_set_id
21693ee2-cd23-4137-ac67-066bb3a4a9b7
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class